The Philosophy
Patient friction creates revenue leakage.
Gross-to-Net is not a finance problem that happens at quarter end. It is the financial echo of how well the enterprise executed the patient journey.
Start here
A prescription is not therapy
A prescription is permission to begin a journey. Most patients assume that once a doctor writes one, treatment begins. In reality there are numerous steps between the prescription and the therapy, and at every stage a patient can meet a barrier, a delay, an administrative requirement or a moment of uncertainty.
Every one of those moments is also a commercial event. When a patient stops, revenue that was forecast never arrives. Not as a rejection, not as a denial, not as a reversal. It simply never shows up, and nothing in the commercial data set records why.
Patients do not experience healthcare through organizational charts.
They experience one continuous journey. The enterprise experiences it as ten separate functions, each measuring its own segment, each correct about its own segment, and none of them holding the whole.
The patient's path
The 10 Exits of Therapy™
Ten points where a patient can become discouraged, delayed or disconnected. Each one is a place a patient leaves. In blue, what it costs the enterprise when they do.
Diagnosis
No diagnosis, no prescription, no record the patient existed
Provider Access
The delay begins before your product is ever considered
Prescription Creation
Fills that stall before the pharmacy ever sees them
Enrollment
The program you funded only works for patients who finish the forms
Coverage
Your contract decides who is allowed to start
Authorization
A wait with no clock, and no owner watching it
Affordability
A deduction you fund, spent on patients who may still leave
Fulfillment
Approval is not arrival
Patient Engagement
Approved patients who never start, for want of a returned call
Therapy Initiation
The last exit, and the one nobody is measured on
The enterprise view
The 5 Layers of GTN™
The same journey, as the enterprise records it. The layers are sequential and causal, which is why a problem that surfaces in Layer 5 was almost always created in Layer 2, 3 or 4. Here is where each of the ten exits lands, and they do not distribute evenly.
Where the number is first imagined
Becomes a population that was forecast and never located. Every later variance then gets explained by uptake, price or channel, because those are the only variables anyone can still see.
Read Layer 01 articles →Whether the patient is permitted to get there
Becomes rebates paid for access, and abandonment during a wait nobody owns. You bought the formulary position. The utilization management came with it.
Read Layer 02 articles →How it physically reaches them
Becomes chargebacks, 340B and fees, plus site-of-care drift that moves your net price without anyone changing a price.
Read Layer 03 articles →Whether they can afford to start and stay
Becomes copay and program spend, and approved patients who never convert to a first fill. Four of the ten exits land here, twice as many as any other layer, and this is the layer owned by a function that is not measured on Gross-to-Net.
Read Layer 04 articles →What all of it did to net revenue
Catches no exit directly. It receives the consequence of every one of them, months later, as a single number it is then asked to explain. Layer 5 does not have a measurement problem. It has a measurement inheritance.
Read Layer 05 articles →Every article in the Knowledge Library is filed by the layer that created the problem rather than the layer that noticed it.
What it asks of a manufacturer
Patients + Profitability™ is not a slogan about doing good
It is a claim about causation. Patient access and profitability are not competing priorities that need balancing. They are the same variable observed from two seats, and they rise and fall together.
A patient who cannot get diagnosed is a forecast that was never real. A patient who abandons at authorization is a rebate you paid for access nobody used. A patient who cannot afford the copay is a deduction that bought nothing. A patient who never returns the call is a hub investment with no yield.
Which means the practical instruction is uncomfortable and specific. Stop treating patient friction as a service quality issue and start treating it as a financial one. Not because patients deserve better, though they do, but because the friction is already in your Gross-to-Net and you are already paying for it. You simply are not attributing it.
You are not choosing between the patient and the number. You are choosing whether to see that they are the same number.
Patients + Profitability™ began as a body of work outside this curriculum, in a podcast and twenty years of arguing the case in rooms where it was not yet obvious. The fuller philosophy, and where it came from, is at patrickrcoyle.com/philosophy.
Where this goes next
Gross-to-Net is where it shows up first, not where it stops
GTN is the first place this logic becomes visible, because GTN is measured, reconciled and defended every quarter. But the same question governs every dollar of commercial spend: which patient was this justified by, and did that patient ever arrive?
Territory design and call plans built on prescriber potential that assumes a patient population somebody located.
Demand generation into exits that were never instrumented. You can create awareness at Exit 1 and lose it at Exit 6.
Insight purchased from the seats that see one segment each, without a framework that reconciles what they say.
Messaging that answers a clinical objection when the actual barrier was administrative.
Every line justified by a forecast, and every forecast justified by patients who have to survive ten exits to become revenue.
Same discipline, wider aperture. Name the outcome, name the patient it depends on, then name who owns the transition in between.
The philosophy is free. The application is the work.
Reading this changes nothing on its own. The curriculum teaches both sides of it, and the Labs put the people who own each layer in the same room until they agree who owns what.
Frequently asked questions about the philosophy
What does "patient friction creates revenue leakage" mean?
Every step between a prescription and a therapy is a place a patient can meet a barrier, a delay, an administrative requirement or a moment of uncertainty. Each of those moments is also a commercial event. When a patient stops, revenue that was forecast never arrives. Not as a rejection or a denial. It simply never shows up, and nothing in the commercial data set records why.
Why is a prescription not therapy?
A prescription is permission to begin a journey. Most patients assume treatment begins once a licensed prescriber writes one, but there are numerous steps between the prescription and the first dose, spread across coverage, prior authorization, benefits verification, affordability, fulfillment and engagement. Therapy begins only when the patient clears all of them.
Why is Gross-to-Net not a finance problem?
Gross-to-Net is the financial echo of how well the enterprise executed the patient journey. It becomes visible in Finance at quarter end, but it is created upstream by contracting, channel design, patient support, affordability programs and payer behavior. Fixing it inside Finance alone means explaining variances after the fact instead of preventing them.
What are The 10 Exits of Therapy™?
The ten sequential points where a patient can delay or discontinue: Diagnosis, Provider Access, Prescription Creation, Enrollment, Coverage, Authorization, Affordability, Fulfillment, Patient Engagement and Therapy Initiation. Three happen before a prescription exists and seven after it is written. Each exit gets a measurement so the leak can be seen, sized and owned.
What is The Silent Leak™?
The patients who leave before any system records them. They are not denied. They are never counted. Approval metrics only capture prior authorizations that were submitted, so an organization can report a healthy approval rate while losing patients it never saw. It is usually the largest line on the revenue waterfall with no assigned owner.
Definitions of the terms used here: the Patients + Profitability™ Glossary.